Pacira Biosciences Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Hi. Good morning, everyone, and thank you for joining us today. So my name is Balaji Prasad.
And continuing on with the spec pharma track for the day today, we have the management team from Pacira with us today. So we have Dave Stack, Chairman and CEO; and Charlie Reinhart, CFO, with us on the call.
Dave, Charlie. Good morning. Thank you for joining us. Would you like to start with a couple of opening comments [and -- or go] more into a fireside chat?
I think, Balaji, time is short. I think we usually do best here when we just jump right into Q&A, if that's okay with you.
Questions & Answers
Absolutely. So I just want to start off with the news that had come out, the Feb sales number that came out this morning. So we have 8% sales in January, 3% in Feb. You have indicated that Q1 is probably
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
